Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience

Abstract

Our findings confirm guselkumab as an appropriate therapeutic option in routine clinical practice, especially when dealing with complex patients with comorbidities or previous failure to biologic treatments.